Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

  • Mina D. Aziz
  • , Jay Shah
  • , Urvi Kapoor
  • , Christina Dimopoulos
  • , Sarah Anand
  • , Allan Augustine
  • , Francis Ayuk
  • , Mohammed Chaudhry
  • , Yi Bin Chen
  • , Hannah K. Choe
  • , Aaron Etra
  • , Stephanie Gergoudis
  • , Matthew J. Hartwell
  • , Elizabeth O. Hexner
  • , William J. Hogan
  • , Carrie L. Kitko
  • , Steven Kowalyk
  • , Nicolaus Kröger
  • , Pietro Merli
  • , George Morales
    • Ryotaro Nakamura, Rainer Ordemann, Michael A. Pulsipher, Muna Qayed, Ran Reshef, Wolf Rösler, Tal Schechter, Elisabeth Schreiner, Hrishikesh Srinagesh, Matthias Wölfl, Kitsada Wudhikarn, Gregory Yanik, Rachel Young, Umut Özbek, James L.M. Ferrara, John E. Levine

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology